Cargando…

Efficacy of continuous erythropoietin receptor activator for end-stage renal disease patients with renal anemia before and after peritoneal dialysis initiation

BACKGROUND: Serial management of renal anemia using continuous erythropoietin receptor activator (CERA) throughout the peritoneal dialysis initiation period has rarely been reported. We investigated the efficacy and dosage of CERA treatment from pre- to post-peritoneal dialysis initiation for anemia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujimoto, Daisuke, Adachi, Masataka, Miyasato, Yoshikazu, Hata, Yusuke, Inoue, Hideki, Oda, Akira, Kakizoe, Yutaka, Nakagawa, Terumasa, Shimasaki, Akiko, Nakamura, Keishi, Nagayoshi, Yu, Mukoyama, Masashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880977/ https://www.ncbi.nlm.nih.gov/pubmed/33025233 http://dx.doi.org/10.1007/s10157-020-01973-x

Ejemplares similares

A Serine Protease Inhibitor, Camostat Mesilate, Suppresses Urinary Plasmin Activity and Alleviates Hypertension and Podocyte Injury in Dahl Salt-Sensitive Rats
por: Iwata, Yasunobu, et al.
Publicado: (2023)

Sirtuin 7 Deficiency Ameliorates Cisplatin-induced Acute Kidney Injury Through Regulation of the Inflammatory Response
por: Miyasato, Yoshikazu, et al.
Publicado: (2018)

Liddle’s-like syndrome associated with nephrotic syndrome secondary to membranous nephropathy: the first case report
por: Yamaguchi, Eriko, et al.
Publicado: (2018)

A Single Arm Clinical Study on the Effects of Continuous Erythropoietin Receptor Activator Treatment in Non-Dialysis Patients with Chronic Heart Failure and Renal Anemia
por: Sezai, Akira, et al.
Publicado: (2023)

Effect of achieved hemoglobin level on renal outcome in non-dialysis chronic kidney disease (CKD) patients receiving epoetin beta pegol: MIRcerA CLinical Evidence on Renal Survival in CKD patients with renal anemia (MIRACLE-CKD Study)
por: Hayashi, Terumasa, et al.
Publicado: (2018)

Successful Introduction of Peritoneal Dialysis in an End-stage Renal Failure Patient with Idiopathic Aplastic Anemia
por: Suzuki, Yasuhiro, et al.
Publicado: (2020)

Erythropoietin and renal protection
por: Baradaran, Azar, et al.
Publicado: (2013)

Efficacy of Roxadustat on anemia and residual renal function in patients new to peritoneal dialysis
por: Wu, Tong, et al.
Publicado: (2022)

Molidustat for Japanese Patients With Renal Anemia Receiving Dialysis
por: Akizawa, Tadao, et al.
Publicado: (2021)

Efficacy and safety of recombinant human erythropoietin (Hema-Plus(®)) for management of anemia in Thai patients on peritoneal dialysis
por: Chuengsaman, Piyatida, et al.
Publicado: (2021)

Isolation and Characterization of Renal Erythropoietin-Producing Cells from Genetically Produced Anemia Mice
por: Pan, Xiaoqing, et al.
Publicado: (2011)

Nanomedicines in the treatment of anemia in renal disease: focus on CERA (Continuous Erythropoietin Receptor Activator)
por: Panchapakesan, Usha, et al.
Publicado: (2007)

Renal Cell Protection of Erythropoietin beyond Correcting The Anemia in Chronic Kidney Disease Patients
por: Nasri, Hamid
Publicado: (2014)

Lipocalin-2, Soluble Transferrin Receptor, and Erythropoietin in Anemia During Mild Renal Dysfunction
por: Nahm, Chung Hyun, et al.
Publicado: (2023)

Suppression of Indoxyl Sulfate Accumulation Reduces Renal Fibrosis in Sulfotransferase 1a1-Deficient Mice
por: Hou, Huixian, et al.
Publicado: (2023)

Effect of peritoneal dialysis versus hemodialysis on renal anemia in renal in end-stage disease patients: a meta-analysis
por: Wang, Wan-Ning, et al.
Publicado: (2016)

Prognostic Nutritional Index as a Predictor of Mortality in 101,616 Patients Undergoing Hemodialysis
por: Miyasato, Yoshikazu, et al.
Publicado: (2023)

A prospective observational study of early intervention with erythropoietin therapy and renal survival in non-dialysis chronic kidney disease patients with anemia: JET-STREAM Study
por: Akizawa, Tadao, et al.
Publicado: (2016)

Siwu Granules and Erythropoietin Synergistically Ameliorated Anemia in Adenine-Induced Chronic Renal Failure Rats
por: Wu, Yansheng, et al.
Publicado: (2019)

TSS-Seq analysis of low pH-induced gene expression in intercalated cells in the renal collecting duct
por: Izumi, Yuichiro, et al.
Publicado: (2017)

Thyroid function analysis after roxadustat or erythropoietin treatment in patients with renal anemia: a cohort study
por: Zheng, Xiaomeng, et al.
Publicado: (2023)

Soluble Erythropoietin Receptor Contributes to Erythropoietin Resistance in End-Stage Renal Disease
por: Khankin, Eliyahu V., et al.
Publicado: (2010)

Comparison of efficacy of roxadustat and erythropoietin for the treatment of renal anemia in patients with chronic kidney disease: a retrospective study
por: Jin, Chen, et al.
Publicado: (2022)

Safety and Efficacy of Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors vs. Erythropoietin-Stimulating Agents in Treating Anemia in Renal Patients (With or Without Dialysis): A Meta-Analysis and Systematic Review
por: Damarlapally, Nanush, et al.
Publicado: (2023)

Functional significance of erythropoietin in renal cell carcinoma
por: Morais, Christudas, et al.
Publicado: (2013)

Renal erythropoietin-producing cells in health and disease
por: Souma, Tomokazu, et al.
Publicado: (2015)

Advances in Understanding the Effects of Erythropoietin on Renal Fibrosis
por: Zhang, Yangyang, et al.
Publicado: (2020)

Erythropoietin production in renal cell carcinoma and renal cysts in autosomal dominant polycystic kidney disease in a chronic dialysis patient with polycythemia: A case report
por: ITO, KEIICHI, et al.
Publicado: (2014)

Renal anemia and hydration status in non-dialysis chronic kidney disease: Is there a link?
por: Hildegard Stancu, Simona, et al.
Publicado: (2018)

Low erythropoietin levels predict faster renal function decline in diabetic patients with anemia: a prospective cohort study
por: Fujita, Yohei, et al.
Publicado: (2019)

Effect of Zinc Supplementation on Renal Anemia in 5/6-Nephrectomized Rats and a Comparison with Treatment with Recombinant Human Erythropoietin
por: Feng, Hui-Lin, et al.
Publicado: (2019)

The Predictive Parameters of Erythropoietin Hyporesponsiveness in Patients on Continuous Ambulatory Peritoneal Dialysis
por: Kim, Jeong Ki, et al.
Publicado: (2001)

Comparison of Oral Recombinant Erythropoietin and Subcutaneous Recombinant Erythropoietin in Prevention of Anemia of Prematurity
por: Saeidi, R, et al.
Publicado: (2012)

Renal tubular acidosis complicated with hyponatremia due to cortisol insufficiency
por: Izumi, Yuichiro, et al.
Publicado: (2015)

Efficacy & safety of continuous erythropoietin receptor activator (CERA) in treating renal anaemia in diabetic patients with chronic kidney disease not on dialysis
por: Vankar, Sameer G., et al.
Publicado: (2014)

Residual renal function in chronic dialysis is not associated with reduced erythropoietin-stimulating agent dose requirements: a cross-sectional study
por: Louw, Elizabeth Helene, et al.
Publicado: (2017)

Polycythemia with Renal Cell Carcinoma and Normal Erythropoietin Level
por: Kopel, Jonathan, et al.
Publicado: (2019)

Gliflozins, Erythropoietin, and Erythrocytosis: Is It Renal Normoxia- or Hypoxia-Driven?
por: Heyman, Samuel N., et al.
Publicado: (2023)

Myelodysplastic syndrome: the other cause of anemia in end-stage renal disease patients undergoing dialysis
por: Chang, Min-Yu, et al.
Publicado: (2020)

Peritoneal dialysis catheter outcomes in infants initiating peritoneal dialysis for end-stage renal disease
por: Imani, Peace D., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sc74513rtirg3sehrrakhv2bie